Graham Juan
SEC insider (Form 3/4/5 filer). CIK 0001879223. Chief Financial Officer at Perspective Therapeutics, Inc. (CATX) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Mar 28, 2025. Located in SEATTLE, WA.
Companies Graham Juan has filed insider reports for
- Perspective Therapeutics, Inc. (CATX): Officer, Chief Financial Officer
- FIBROGEN INC (FGEN): Officer, CHIEF FINANCIAL OFFICER
Graham Juan
CIK: 0001879223
Transaction Breakdown
Open Market Buys (P)1 (16.7%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (16.7%)
Compensation grants
Other (G, F, J, C, D, …)4 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 28, 2025CATX
Perspective Therapeutics, Inc.
PurchaseDirect33.3K shares at avg. $2.25$75K - Jan 6, 2025CATX
Perspective Therapeutics, Inc.
AwardDirectStock option (right to buy)
400K shares- - Dec 7, 2024FGEN
FIBROGEN INC
Tax PaymentDirect1.1K shares at avg. $0.34$364.679 - Dec 6, 2024FGEN
FIBROGEN INC
Tax PaymentDirect1.4K shares at avg. $0.34$494.677 - Sep 7, 2024FGEN
FIBROGEN INC
Tax PaymentDirect1.1K shares at avg. $0.39$415.35 - Sep 6, 2024FGEN
FIBROGEN INC
Tax PaymentDirect16.1K shares at avg. $0.39$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 28, 2025 |  CATX Perspective Therapeutics, Inc. | Purchase | 33,333 | $2.25 | $74,946 | Direct |
| Jan 6, 2025 | CATX Perspective Therapeutics, Inc. | Award Stock option (right to buy) | 400,000 | - | - | Direct |
| Dec 7, 2024 |  FGEN FIBROGEN INC | Tax Payment | 1,066 | $0.34 | $365 | Direct |
| Dec 6, 2024 | FGEN FIBROGEN INC | Tax Payment | 1,446 | $0.34 | $495 | Direct |
| Sep 7, 2024 | FGEN FIBROGEN INC | Tax Payment | 1,065 | $0.39 | $415 | Direct |
| Sep 6, 2024 | FGEN FIBROGEN INC | Tax Payment | 16,050 | $0.39 | $6,260 | Direct |
1-6 of 6 transactions